Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
qHTS for PTHR1 Agonists: Optimization Screen against the NCGC LOPAC library
Assay data:10 Active, 1279 Tested
SummaryCompounds, ActiveRelated BioAssays by DepositorRelated BioAssays by Same ProjectRelated BioAssays by Target
qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC)
Assay data:44 Active, 15 Activity ≤ 1 µM, 1366 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Hit Validation in HTRF
Assay data:50 Active, 78 Activity ≤ 1 µM, 1280 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Same ProjectRelated BioAssays by Target
qHTS of GLP-1 Receptor Agonists: LOPAC Validation
Assay data:2 Active, 14 Activity ≤ 1 µM, 1280 Tested
Modulators of the EP2 prostaglandin E2 receptor - Primary Screening
Assay data:2162 Active, 262043 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by DepositorRelated BioAssays by Target
NCI In Vivo Anticancer Drug Screen. Data for tumor model Human Mammary Carcinoma MX-1 Xenograft (intrarenal inoculation) in NU/NU BALB/C (nude) mice
Assay data:31 Active, 620 Tested
SummaryCompounds, Active
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on